Skip to content

PREVALENCE SURVEY OF PLASMODIUM FALCIPARUM ANTIMALARIAL DRUG RESISTANCE MARKERS AT SITES IN INDIA

PREVALENCE SURVEY OF PLASMODIUM FALCIPARUM ANTIMALARIAL DRUG RESISTANCE MARKERS AT SITES IN INDIA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20171128005
Enrollment
400
Registered
2017-11-28
Start date
2018-02-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria disease Malaria disease

Interventions

Patients Presenting P. falciparum Malaria
Health Services Research

Sponsors

St. John Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 75 Years

Inclusion criteria

Inclusion criteria: Participants must meet all of the inclusion criteria to participate in the study. -Patients (6 months - 75 years) with confirmed uncomplicated P. falciparum infection -Written informed consent obtained All participants meeting inclusion criteria will have their dried blood spots retained for parasite molecular analyses.

Exclusion criteria

Exclusion criteria: Patients presenting signs of severe malaria will be excluded from the survey to prevent any delay in the management of the patient.

Design outcomes

Primary

MeasureTime frame
Prevalence and geospatial trends of Molecular markers 1 year Surveillance

Secondary

MeasureTime frame
Visualization and dissemination of molecular marker prevalence data to inform public health official 1 year Mapping

Countries

India

Contacts

Public ContactMehul Dhorda

WWARN

Mehul.Dhorda@wwarn.org66023 54 91 28

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026